Founded in 2011 and headquartered in Houston, Texas, Saranas is a medical device company dedicated to minimizing complications associated with interventional or surgical procedures. Its core mission is to enhance patient safety by providing innovative solutions for internal bleeding detection during catheterization. The company's flagship product, the Early Bird® Bleed Monitoring System, is designed to detect and monitor internal bleeding in real-time, thereby improving clinical outcomes and reducing procedural risks.
Saranas has garnered attention from notable investors and industry experts due to its groundbreaking technology. The Early Bird® system has been recognized for its clinical performance and has been featured in various medical literature and case studies. The company's impact is evident in its contribution to safer medical practices, potentially saving lives by enabling timely intervention during high-risk procedures.
